Product Description

Bendazee 100 mg Injection contains Bendamustine 100 mg, an alkylating antineoplastic medicine used in chemotherapy. It is primarily used for certain B-cell blood cancers, including chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).

🔹 Composition
Brand Name: Bendazee 100 mg
Active Ingredient: Bendamustine
Strength: 100 mg
Dosage Form: Lyophilized powder for injection
Therapeutic Class: Antineoplastic / Alkylating agent
Manufacturer/Marketer: Zee Laboratories Ltd.

🔹 Uses & Indications
Bendazee 100 mg Injection may be prescribed for:
Chronic lymphocytic leukemia (CLL)
Indolent B-cell non-Hodgkin lymphoma (NHL)
Other malignancies where bendamustine is included in an oncologist-directed chemotherapy regimen.

🔹 How Bendamustine Works
Bendamustine is an alkylating agent that damages the DNA of cancer cells. This interferes with DNA replication and cell division, helping inhibit the growth and survival of malignant cells.

🔹 Key Benefits
Provides bendamustine-based chemotherapy for appropriate blood cancers.
Can be incorporated into combination treatment protocols.
Available as a 100 mg lyophilized injectable formulation.

🔹 Dosage & Administration
The dose and treatment schedule depend on the type of cancer, chemotherapy protocol, blood counts, organ function, and individual patient factors.
Bendazee should be prepared and administered by qualified healthcare professionals. It is not intended for self-administration.

🔹 Common Side Effects
Possible adverse effects include:
Nausea and vomiting
Fatigue
Fever
Diarrhea or constipation
Decreased appetite
Headache
Rash
Injection-site reactions
Reduced blood cell counts, including low platelets

Bendamustine may also cause serious myelosuppression, infections, hypersensitivity reactions, severe skin reactions, and tumor lysis syndrome, requiring appropriate medical monitoring.

🔹 Precautions & Warnings
Use only under the supervision of an oncologist.
Blood counts should be monitored during treatment.
Inform the doctor about existing liver or kidney disease and active infections.
Tell the healthcare team about all medicines being taken because clinically important drug interactions may occur.
Bendamustine can cause embryo-fetal toxicity; pregnancy should be avoided during treatment according to medical advice.
Breastfeeding should be discussed with the treating oncologist.
Seek urgent medical attention for high fever, severe allergic reactions, breathing difficulty, or signs of infection.